National Institutes of Health, Office of Purchasing and Contracts, CC 6006 Executive Blvd., Suite 311, Bethesda, MD 20892-7058

66 -- CELL SEPERATOR SOL CC-95-15 DUE 082895 POC Lynniese Cosey, Contract Specialist (301) 496-3704, Patrick Williams, Contracting Officer (301) 496-3704. The National Institutes of Health, Clinical Center has a requirement to procure a Baxter CS-3000 Cell Seperator on a source basis under the authority of 41 U.S.C. 253(c)(1) as set forth in FAR 6.301-1. The required characteristics of the cell seperator are: (1) Unique sealless design of CS-3000 Plus to reduce the risk of bacterial contamination to the product and operator exposure to aerosols. (2) A low extracorporal volume reduces the risk of hypovolemic reactions. (3) Warms blood before returning it to the donor or patient. Provide high yeilds and a pure product. (4) Seperation of patients blood into cells and plasma, such as: Plasma exchange, Red cell exchange, Therapeutic cell reductions, Lymphocyte collections, and Lymphoplasma exchange. (5) Direct reprogramming and editing capabilities for modifying procedures making it ideal for research protocols. Capability to store eight modified programs in permanent memory, eliminating the need to reprogram. (6) Schedule staff and donor for platelet collections without worrying about 24 hours outdate. (7) ability to simultaneously collect up to 500 ml of plasma in a seperate preattached transfer pack unit with each therapeutic dose of platelets. (8) Preoperatively collects platelets for elective surgery. Any other firm that believes that it has the ability to meet the Government requirement is invited to respond to this notice by furnishing a capability statement demonstrating their ability to meet, at a minimum, all stated features of the Government required equipment. See Numbered Note(s): 22. (0195)

Loren Data Corp. http://www.ld.com (SYN# 0538 19950717\66-0003.SOL)